Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
The tablets used were different colours. Has it crossed anyone's mind
that it
might have been the colouring in the tablets and not the folate that
caused
the insignificant rise in breast cancer? Some excipients in medicines are
responsible for side-effects in sensitive people, such as lactose. Azo
dyes are
known to be carcinogenic. Can the authors confirm whether all the
colourings
used in this trial are known to be safe?
Coloured Pills
The tablets used were different colours. Has it crossed anyone's mind that it might have been the colouring in the tablets and not the folate that caused the insignificant rise in breast cancer? Some excipients in medicines are responsible for side-effects in sensitive people, such as lactose. Azo dyes are known to be carcinogenic. Can the authors confirm whether all the colourings used in this trial are known to be safe?
Competing interests: None declared
Competing interests: No competing interests